FLEX 2026 Marks 25 Years of Electronics Innovation
MILPITAS, Calif., January 22, 2026 — SEMI announced that the FLEX Technology Summit 2026 will take place February 24–26,...
AI in Healthcare Alzheimer’s Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy cGxP Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP GMP compliance Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
MILPITAS, Calif., January 22, 2026 — SEMI announced that the FLEX Technology Summit 2026 will take place February 24–26,...
BEIJING — November 27, 2025. Gan & Lee Pharmaceuticals has initiated GRADUAL-3, its third Phase 3 clinical study evaluating...
AUSTIN, Texas & TOKYO — November 27, 2025. A new global analysis reports that the In-Silico Clinical Trials (IST)...
